HNRNPA2B1 | Heterogeneous nuclear ribonucleoprotein A2/B1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
HOOK3 | Hook microtubule-tethering protein 3 | Cancer-related genes
| | | | | Expressed in all |
HOXA11 | Homeobox A11 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
HOXA9 | Homeobox A9 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
HOXC11 | Homeobox C11 | Cancer-related genes Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
HOXC13 | Homeobox C13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
HOXD13 | Homeobox D13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
HRAS | Harvey rat sarcoma viral oncogene homolog | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
HSP90AA1 | Heat shock protein 90kDa alpha (cytosolic), class A member 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
HSP90AB1 | Heat shock protein 90kDa alpha (cytosolic), class B member 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
IDH2 | Isocitrate dehydrogenase 2 (NADP+), mitochondrial | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IL2 | Interleukin 2 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Not detected |
IL21R | Interleukin 21 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
ITK | IL2-inducible T-cell kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
JAK1 | Janus kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
JAK2 | Janus kinase 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
JAK3 | Janus kinase 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
JAZF1 | JAZF zinc finger 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
KAT6A | K(lysine) acetyltransferase 6A | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
KAT6B | K(lysine) acetyltransferase 6B | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KDM5A | Lysine (K)-specific demethylase 5A | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KDM5C | Lysine (K)-specific demethylase 5C | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
KDM6A | Lysine (K)-specific demethylase 6A | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KDSR | 3-ketodihydrosphingosine reductase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
KIAA1549 | KIAA1549 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
KIF5B | Kinesin family member 5B | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KLF4 | Kruppel-like factor 4 (gut) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KLF6 | Kruppel-like factor 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
KLK2 | Kallikrein-related peptidase 2 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Transcription factors
| | | | | Expressed in all |
KMT2C | Lysine (K)-specific methyltransferase 2C | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
KMT2D | Lysine (K)-specific methyltransferase 2D | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
KRAS | Kirsten rat sarcoma viral oncogene homolog | Cancer-related genes Disease related genes RAS pathway related proteins
| | | | | Expressed in all |
KTN1 | Kinectin 1 (kinesin receptor) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
LASP1 | LIM and SH3 protein 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
LCK | Lymphocyte-specific protein tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
LCP1 | Lymphocyte cytosolic protein 1 (L-plastin) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
LHFP | Lipoma HMGIC fusion partner | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
LIFR | Leukemia inhibitory factor receptor alpha | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |